Hao Li
47Patents
10h-index
117Co-inventors
78Inventor score
Filing activity: Aug 29, 2002 → May 13, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7615552B2 | Fused heterocyclic compounds | Chemistry; Metallurgy | 87 | Active |
| US8053456B2 | Triazole compounds that modulate Hsp90 activity | Chemistry; Metallurgy | 49 | Active |
| US8318790B2 | Triazole compounds that modulate HSP90 activity | Chemistry; Metallurgy | 45 | Active |
| US8415377B2 | Triazole compounds that modulate HSP90 activity | Chemistry; Metallurgy | 38 | Active |
| US8742133B2 | Triazole compounds that modulate HSP90 activity | Chemistry; Metallurgy | 33 | Active |
| US8835464B2 | Triazole compounds that modulate HSP90 activity | Chemistry; Metallurgy | 31 | Active |
| US7709518B2 | Compounds for inflammation and immune-related uses | Emerging Cross-Sectional Technologies | 30 | Active |
| US7919487B2 | Heteroaryl compounds | Chemistry; Metallurgy | 29 | Active |
| US8324184B2 | Anti-adhesion composites and methods of use thereof | Human Necessities | 21 | Active |
| US7338951B2 | Pyridine compounds | Chemistry; Metallurgy | 10 | Expired |
| US8927548B2 | Triazole compounds that modulate HSP90 activity | Chemistry; Metallurgy | 10 | Active |
| US9006277B2 | Triazole compounds that modulate HSP90 activity | Chemistry; Metallurgy | 7 | Active |
| US10555942B2 | Emetine compounds for treatment and prevention of flavivirus infection | Emerging Cross-Sectional Technologies | 7 | Active |
| US10632209B2 | ASH1L inhibitors and methods of treatment therewith | Chemistry; Metallurgy | 7 | Active |
| US9206162B2 | Triazole compounds that modulate Hsp90 activity | Chemistry; Metallurgy | 5 | Active |
| US9120745B2 | Triazole compounds that modualte HSP90 activity | Chemistry; Metallurgy | 5 | Active |
| US11147885B2 | ASH1L inhibitors and methods of treatment therewith | Chemistry; Metallurgy | 3 | Active |
| US9120799B2 | Crystalline bipyridinium radical complexes and uses thereof | Electricity | 3 | Active |
| US8269017B2 | Compounds for the treatment of proliferative disorders | Chemistry; Metallurgy | 3 | Active |
| US11110177B2 | ASH1L degraders and methods of treatment therewith | Chemistry; Metallurgy | 2 | Active |
| US8524756B2 | Compounds for inflammation and immune-related uses | Emerging Cross-Sectional Technologies | 2 | Active |
| US8173651B2 | Pyridine compounds | Chemistry; Metallurgy | 2 | Active |
| US7687498B2 | Pyridine compounds | Chemistry; Metallurgy | 2 | Active |
| US6861436B2 | 1-glyoxylamide indolizines for treating cancer | Human Necessities | 2 | Expired |
| US7884094B2 | Compounds for the treatment of proliferative disorders | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.